Cargando…
Metabolic Acidosis Due To Pyroglutamic Acid
Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346886/ https://www.ncbi.nlm.nih.gov/pubmed/30755980 http://dx.doi.org/10.12890/2018_000949 |
_version_ | 1783389842381471744 |
---|---|
author | Serpa, Maria João Falcão, Luís Franco, Susana Repolho, Diana Ferreira, Nuno Ribeiro |
author_facet | Serpa, Maria João Falcão, Luís Franco, Susana Repolho, Diana Ferreira, Nuno Ribeiro |
author_sort | Serpa, Maria João |
collection | PubMed |
description | Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K(+), Ca2(+), Mg2(+)) or an increase in unmeasured anions (PO(4)(3−), albumin). However, other anions such as lactic acid or keto acids may cause this acid-base disorder. It can also result from renal failure and intoxication (salicylate, methanol, ethylene glycol), or more rarely, from massive rhabdomyolysis and pyroglutamic (5-oxoproline) acidemia. Acidemia due to pyroglutamic acid should be considered when no other aetiology is found. High anion gap metabolic acidosis is diagnosed in children with inherited defects in enzymes of the γ-glutamyl cycle. In adults, this disorder from pyroglutamic acid has been described in association with chronic acetaminophen misuse. We report a case of pyroglutamic acidosis in a woman with acute misuse of acetaminophen concurrent with chronic use. LEARNING POINT: Paracetamol is an easily available drug with potentially harmful consequences. Accumulation of pyroglutamic acid (5-oxoproline) may be a cause of high anion gap metabolic acidosis. Reporting cases of 5-oxoprolinemia acidosis contributes to better understanding of the condition. |
format | Online Article Text |
id | pubmed-6346886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-63468862019-02-12 Metabolic Acidosis Due To Pyroglutamic Acid Serpa, Maria João Falcão, Luís Franco, Susana Repolho, Diana Ferreira, Nuno Ribeiro Eur J Case Rep Intern Med Articles Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K(+), Ca2(+), Mg2(+)) or an increase in unmeasured anions (PO(4)(3−), albumin). However, other anions such as lactic acid or keto acids may cause this acid-base disorder. It can also result from renal failure and intoxication (salicylate, methanol, ethylene glycol), or more rarely, from massive rhabdomyolysis and pyroglutamic (5-oxoproline) acidemia. Acidemia due to pyroglutamic acid should be considered when no other aetiology is found. High anion gap metabolic acidosis is diagnosed in children with inherited defects in enzymes of the γ-glutamyl cycle. In adults, this disorder from pyroglutamic acid has been described in association with chronic acetaminophen misuse. We report a case of pyroglutamic acidosis in a woman with acute misuse of acetaminophen concurrent with chronic use. LEARNING POINT: Paracetamol is an easily available drug with potentially harmful consequences. Accumulation of pyroglutamic acid (5-oxoproline) may be a cause of high anion gap metabolic acidosis. Reporting cases of 5-oxoprolinemia acidosis contributes to better understanding of the condition. SMC Media Srl 2018-10-24 /pmc/articles/PMC6346886/ /pubmed/30755980 http://dx.doi.org/10.12890/2018_000949 Text en © EFIM 2018 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Articles Serpa, Maria João Falcão, Luís Franco, Susana Repolho, Diana Ferreira, Nuno Ribeiro Metabolic Acidosis Due To Pyroglutamic Acid |
title | Metabolic Acidosis Due To Pyroglutamic Acid |
title_full | Metabolic Acidosis Due To Pyroglutamic Acid |
title_fullStr | Metabolic Acidosis Due To Pyroglutamic Acid |
title_full_unstemmed | Metabolic Acidosis Due To Pyroglutamic Acid |
title_short | Metabolic Acidosis Due To Pyroglutamic Acid |
title_sort | metabolic acidosis due to pyroglutamic acid |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346886/ https://www.ncbi.nlm.nih.gov/pubmed/30755980 http://dx.doi.org/10.12890/2018_000949 |
work_keys_str_mv | AT serpamariajoao metabolicacidosisduetopyroglutamicacid AT falcaoluis metabolicacidosisduetopyroglutamicacid AT francosusana metabolicacidosisduetopyroglutamicacid AT repolhodiana metabolicacidosisduetopyroglutamicacid AT ferreiranunoribeiro metabolicacidosisduetopyroglutamicacid |